Acquisition - October 13, 2014
Meda launches rights issue to help pay for Rottapharm
As part of the financing of the acquisition of Rottapharm, Meda’s Board of Directors has resolved to launch a rights issue of approximately SEK 2.0 billion. On 31 July 2014, Meda announced entering into an agreement to acquire the Italian specialty pharma company Rottapharm S.p.A. Completion of the transaction was subject to certain conditions, including […]
Acquisition - July 31, 2014
Meda acquires Rottapharm
Meda has entered into a definitive agreement to acquire Italian firm Rottapharm for a consideration of SEK 21.2 billion. The consideration will comprise SEK 15.3 billion (€1.643 billion) in cash, 30 million Meda shares corresponding to a value of SEK 3.3 billion (€357 million) and a non-contingent deferred payment in January 2017 of SEK 2.6 billion […]